Vaxil Bio Ltd (V:VXL) — Stock Price
Vaxil Bio Ltd (V:VXL) is currently trading at CA$0.15 CAD, up 0.00% today. Over the past 52 weeks, shares have ranged between CA$0.13 and CA$0.29. This page tracks Vaxil Bio Ltd's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see Vaxil Bio Ltd (VXL) cash conversion ratio.
Vaxil Bio Ltd (VXL) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Vaxil Bio Ltd's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
Vaxil Bio Ltd Income Statement — Revenue, Profit & Earnings by Year
Vaxil Bio Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 |
| Cost of Revenue | — | — | CA$2.00K | CA$25.00K | CA$57.00K |
| Gross Profit | — | — | CA$-2.00K | CA$-25.00K | CA$-57.00K |
| Research & Development | CA$12.00K | CA$114.00 | CA$343.00K | CA$539.00K | CA$619.00K |
| SG&A | CA$184.00K | CA$120.00 | CA$239.00K | CA$428.00K | CA$724.00K |
| Total Operating Expenses | CA$196.00K | CA$254.00 | CA$584.00K | CA$986.00K | CA$1.35 Million |
| Operating Income | CA$-196.00K | CA$-254.00 | CA$-584.00K | CA$-986.00K | CA$-1.35 Million |
| EBITDA | — | CA$-252.00 | CA$-582.00K | CA$-961.00K | CA$-1.29 Million |
| EBIT | — | CA$-168.15K | CA$-584.00K | CA$-986.00K | CA$-1.35 Million |
| Interest Expense | — | — | — | CA$4.00K | CA$11.00K |
| Income Before Tax | CA$-178.00K | CA$-254.00 | CA$-584.00K | CA$-986.00K | CA$-1.36 Million |
| Income Tax Expense | — | — | — | — | CA$11.00K |
| Net Income | CA$-178.00K | CA$-254.00 | CA$-584.00K | CA$-986.00K | CA$-1.37 Million |
Vaxil Bio Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Vaxil Bio Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CA$733.00K | CA$976.00K | CA$1.54 Million | CA$2.29 Million | CA$1.66 Million |
| Total Current Assets | CA$733.00K | CA$976.00K | CA$1.54 Million | CA$2.28 Million | CA$1.63 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | — | CA$19.00K | CA$20.00K | CA$35.00K | CA$33.00K |
| Inventory | — | CA$18.96K | — | — | — |
| Property, Plant & Equipment | — | — | — | CA$2.00K | CA$27.00K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CA$17.00K | CA$85.00K | CA$405.00K | CA$585.00K | CA$857.00K |
| Total Current Liabilities | CA$17.00K | CA$85.00K | CA$405.00K | CA$585.00K | CA$857.00K |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | CA$-938.00K | CA$-1.51 Million | CA$-2.24 Million | CA$-1.50 Million |
| Total Stockholder Equity | CA$716.00K | CA$891.00K | CA$1.14 Million | CA$1.70 Million | CA$804.00K |
| Retained Earnings | CA$-19.54 Million | CA$-19.36 Million | CA$-19.10 Million | CA$-18.52 Million | CA$-17.53 Million |
Vaxil Bio Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Vaxil Bio Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-240.00K | CA$-561.00K | CA$-734.00K | CA$-1.08 Million | CA$-1.10 Million |
| Capital Expenditures | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 |
| Free Cash Flow | CA$-240.00K | CA$-561.00K | CA$-734.00K | CA$-1.08 Million | CA$-1.10 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | CA$35.00K | CA$1.81 Million | CA$2.56 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$5.00K | CA$20.00K | CA$17.00K | CA$70.00K | CA$150.00K |
| Depreciation | — | CA$0.00 | CA$2.00K | CA$25.00K | CA$57.00K |
| Change in Cash | CA$-490.00K | CA$-572.00K | CA$-731.00K | CA$731.00K | CA$1.43 Million |
Vaxil Bio Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Vaxil Bio Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 23, 2026 | — | — | — |
| Nov 27, 2025 | — | — | — |
| Sep 02, 2025 | — | — | — |
| May 27, 2025 | — | — | — |
| Mar 31, 2023 | 0.00 | — | — |
| Dec 31, 2022 | 0.00 | — | — |
| Sep 30, 2022 | 0.00 | — | — |
| Jun 30, 2022 | 0.00 | — | — |